Clinical Trials Logo
  1. Home
  2. Anterior Uveitis
  3. NCT00333996
  4. Details
NCT00333996 Clinical Trial

A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis

Anterior Uveitis Clinical Trial

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT00333996
Other study ID # 206207-015
Secondary ID
Status Terminated
Phase Phase 2/Phase 3
First received June 2, 2006
Last updated May 27, 2011
Start date May 2006
Est. completion date March 2007

Study information
Verified date May 2011
Source Allergan
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious anterior uveitis.

Recruitment information / eligibility
Status Terminated
Enrollment 5
Est. completion date March 2007
Est. primary completion date March 2007
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years or older with a diagnosis of non-infectious anterior uveitis in at least one eye

Exclusion Criteria:

- Uncontrolled systemic disease

- Any active ocular infections

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Drug:
• Dexamethasone

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Allergan

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Anterior Chamber Cell
See also
  Status Clinical Trial Phase
Completed NCT00476593 - Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications N/A
Recruiting NCT01486693 - Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis N/A
Recruiting NCT01156285 - Acute Anterior Uveitis: Psychic Burden and Pain N/A
Completed NCT00405496 - Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis Phase 2
Completed NCT02764697 - Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients Phase 4
Completed NCT01376362 - Topical Interferon Gamma for Macular Edema Secondary to Uveitis Phase 1/Phase 2
Recruiting NCT00407316 - Quality of Life and Visual Function in Uveitis Patients Phase 0
Completed NCT02725177 - Ocular Sarcoidosis Open Label Trial of ACTHAR Gel N/A
Completed NCT01647529 - Topical Administration of 0.15% Ganciclovir Gel for CMV Anterior Uveitis / Endotheliitis N/A
Completed NCT00823173 - Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis Phase 2
Completed NCT02517619 - Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis Phase 3
Completed NCT01505088 - Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis Phase 3
Completed NCT02879084 - Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis
Completed NCT02765308 - Aqueous Humor Dynamics and Hypertensive Uveitis N/A
Completed NCT01154010 - PEMF: an Adjunct Therapy for Anterior Uveitis N/A
Completed NCT00130637 - Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis Phase 2
Completed NCT00406887 - Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis Phase 3
Completed NCT00876434 - Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti Phase 1